OncBioMune Pharmaceuticals, a Baton Rouge-based firm that has developed a prostate cancer treatment known as ProsaVax, has completed the acquisition of Mexican specialty drug maker Vitel Laboratorios …
OncBioMune Pharmaceuticals, a Baton Rouge-based firm that has developed a prostate cancer treatment known as ProsaVax, has completed the acquisition of Mexican specialty drug maker Vitel Laboratorios …